The expression of miR-125b was compared with the pathological characteristics of the breast cancer patients, including age, tumor size, grade of differentiation, presence of lymph node metastases, number of affected nodules, presence of distant metastases, and the molecular classification of the tumors as described (luminal A, luminal B, HER2+, and triple negative) [28]. Here, ERBB2 is linked to breast cancer.